Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PRADEEP KUMAR SELVARAJ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1053545913
CMS profile
92802
Location
WOODVILLE, MS

General Payments · PY2018–2024

$5,336.48

  • Reported across 386 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$550.39

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $550.39 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $247.07 14
Novo Nordisk AS $156.15 11
Boehringer Ingelheim Pharmaceuticals, Inc. $30.16 2
Lilly USA, LLC $28.55 2
Ardelyx, Inc. $16.60 1
PFIZER INC. $16.05 1
ABBVIE INC. $14.82 1
NOVARTIS PHARMACEUTICALS CORPORATION $13.96 1
Amgen Inc. $13.95 1
Exact Sciences Corporation $13.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,181.23 88
PY2019 $1,049.16 87
PY2020 $706.31 51
PY2021 $754.87 53
PY2022 $478.05 32
PY2023 $616.47 40
PY2024 $550.39 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.82 02/09/2024 Food and Beverage Undisputed 01/23/2026 1106054686 CMS
Amgen Inc. $13.95 02/22/2024 Food and Beverage Undisputed 01/23/2026 1117679703 CMS
Ardelyx, Inc. $16.60 05/08/2024 Food and Beverage Undisputed 01/23/2026 1146706737 CMS
AstraZeneca Pharmaceuticals LP $15.29 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105265214 CMS
AstraZeneca Pharmaceuticals LP $43.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105661518 CMS
AstraZeneca Pharmaceuticals LP $15.84 03/13/2024 Food and Beverage Undisputed 01/23/2026 1105642942 CMS
AstraZeneca Pharmaceuticals LP $14.98 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105501382 CMS
AstraZeneca Pharmaceuticals LP $16.80 04/17/2024 Food and Beverage Undisputed 01/23/2026 1104306324 CMS
AstraZeneca Pharmaceuticals LP $16.05 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105718104 CMS
AstraZeneca Pharmaceuticals LP $14.12 05/29/2024 Food and Beverage Undisputed 01/23/2026 1104690258 CMS
AstraZeneca Pharmaceuticals LP $13.91 07/22/2024 Food and Beverage Undisputed 01/23/2026 1105577334 CMS
AstraZeneca Pharmaceuticals LP $14.45 07/25/2024 Food and Beverage Undisputed 01/23/2026 1105221378 CMS
AstraZeneca Pharmaceuticals LP $16.72 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104323060 CMS
AstraZeneca Pharmaceuticals LP $16.11 09/03/2024 Food and Beverage Undisputed 01/23/2026 1105515193 CMS
AstraZeneca Pharmaceuticals LP $16.11 10/07/2024 Food and Beverage Undisputed 01/23/2026 1105793906 CMS
AstraZeneca Pharmaceuticals LP $13.27 10/22/2024 Food and Beverage Undisputed 01/23/2026 1105881024 CMS
AstraZeneca Pharmaceuticals LP $20.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 1104358315 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.83 02/27/2024 Food and Beverage Undisputed 01/23/2026 1117854383 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.33 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117854385 CMS
Exact Sciences Corporation $13.08 10/29/2024 Food and Beverage Undisputed 01/23/2026 1114885292 CMS
Lilly USA, LLC $13.47 08/07/2024 Food and Beverage Undisputed 01/23/2026 1135326415 CMS
Lilly USA, LLC $15.08 09/18/2024 Food and Beverage Undisputed 01/23/2026 1135290140 CMS
Novartis Pharmaceuticals Corporation $13.96 02/20/2024 Food and Beverage Undisputed 01/23/2026 1087297439 CMS
Novo Nordisk Inc $13.91 01/09/2024 Food and Beverage Undisputed 01/23/2026 1097001932 CMS
Novo Nordisk Inc $16.05 02/13/2024 Food and Beverage Undisputed 01/23/2026 1096689480 CMS
Novo Nordisk Inc $15.29 03/19/2024 Food and Beverage Undisputed 01/23/2026 1096700734 CMS
Novo Nordisk Inc $16.05 04/23/2024 Food and Beverage Undisputed 01/23/2026 1097444451 CMS
Novo Nordisk Inc $11.56 06/18/2024 Food and Beverage Undisputed 01/23/2026 1097784988 CMS
Novo Nordisk Inc $14.27 07/23/2024 Food and Beverage Undisputed 01/23/2026 1096902659 CMS
Novo Nordisk Inc $14.45 08/20/2024 Food and Beverage Undisputed 01/23/2026 1096647386 CMS
Novo Nordisk Inc $12.84 09/16/2024 Food and Beverage Undisputed 01/23/2026 1097378004 CMS
Novo Nordisk Inc $16.05 10/15/2024 Food and Beverage Undisputed 01/23/2026 1096595760 CMS
Novo Nordisk Inc $13.50 11/12/2024 Food and Beverage Undisputed 01/23/2026 1096925876 CMS
Novo Nordisk Inc $12.18 12/02/2024 Food and Beverage Undisputed 01/23/2026 1097102193 CMS
PFIZER INC. $16.05 02/21/2024 Food and Beverage Undisputed 01/23/2026 1131060432 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.